Logo image
Nephrotic syndrome and collagenizing glomerulopathy in PVG/c rats treated with the α-mannosidase inhibitor "swainsonine"
Journal article   Peer reviewed

Nephrotic syndrome and collagenizing glomerulopathy in PVG/c rats treated with the α-mannosidase inhibitor "swainsonine"

C.R. Huxtable and P.R. Dorling
Veterinary Pathology, Vol.20(6), pp.727-736
1983
url
Link to Published Version *Subscription may be requiredView

Abstract

Weanling PVG/c rats treated with the α-mannosidase inhibitor swainsonine developed increasing proteinuria which terminated as a severe nephrotic syndrome after 35 to 45 days. This was associated with a glomerulopathy characterized by the production of collagen fibrils adjacent to endothelial and mesangial cells, foot process expansion, subepithelial projections of the basement membrane, and splitting of the lamina densa. The swainsonine-induced glomerulopathy appeared to be an exacerbation of a spontaneous abnormality in this strain of rat.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.55 Urology & Nephrology - General
1.55.820 Nephrotic Syndrome
Web Of Science research areas
Pathology
Veterinary Sciences
ESI research areas
Plant & Animal Science
Logo image